{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:23:09Z","timestamp":1791573789470,"version":"4.3.4"},"reference-count":56,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The growing threat of antibiotic-resistant Neisseria gonorrhoeae, which causes gonorrhea, presents a current public health challenge. Over the years, the pathogen has developed resistance to different antibiotics, leaving few effective treatment options. High-level resistance to key drugs, including ceftriaxone, has become a concerning reality. This article primarily focuses on the treatment of gonorrhea and the current clinical trials aimed at providing new antibiotic treatment options. We explore ongoing efforts to assess new antibiotics, including zoliflodacin, and gepotidacin. These drugs offer new effective treatment options, but their rapid availability remains uncertain. We delve into two ongoing clinical trials: one evaluating the efficacy and safety of gepotidacin compared to the standard ceftriaxone\u2013azithromycin combination and the other assessing the non-inferiority of zoliflodacin versus the combination therapy of ceftriaxone\u2013azithromycin. These trials represent crucial steps in the search for alternative treatments for uncomplicated gonorrhea. Notably, gonorrhea has been included in the \u201cWHO Priority Pathogens List for Research and Development of New Antibiotics\u201d. In conclusion, the urgent need for innovative treatment strategies is underscored by the rising threat of antibiotic resistance in N. gonorrhoeae; collaboration among researchers, industries, and healthcare authorities is therefore essential.<\/jats:p>","DOI":"10.3390\/jcm12247767","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T11:28:07Z","timestamp":1702898887000},"page":"7767","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Neisseria gonorrhoeae Antimicrobial Resistance: The Future of Antibiotic Therapy"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-6255","authenticated-orcid":false,"given":"Angelo Roberto","family":"Raccagni","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ranzenigo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bruzzesi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Maci","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy"},{"name":"Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2673-2731","authenticated-orcid":false,"given":"Silvia","family":"Nozza","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy"},{"name":"Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"548P","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull. World Health Organ."},{"key":"ref_2","unstructured":"(2016). Global Health Sector Strategy on Sexually Transmitted Infections, 2016\u20132021, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-RHR-16.09."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/jcm3041386","article-title":"High Prevalence of Asymptomatic Sexually Transmitted Infections among Men Who Have Sex with Men","volume":"3","author":"Philibert","year":"2014","journal-title":"J. Clin. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Marchese, V., Tiecco, G., Storti, S., Degli Antoni, M., Calza, S., Gulletta, M., Viola, F., Foc\u00e0, E., Matteelli, A., and Castelli, F. (2022). Syphilis Infections, Reinfections and Serological Response in a Large Italian Sexually Transmitted Disease Centre: A Monocentric Retrospective Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11247499"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Evans, A.M., Salnikov, M., Gameiro, S.F., Maleki Vareki, S., and Mymryk, J.S. (2022). HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct. J. Clin. Med., 11.","DOI":"10.3390\/jcm11164825"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1071\/SH19061","article-title":"Epidemiology of gonorrhoea: A global perspective","volume":"16","author":"Kirkcaldy","year":"2019","journal-title":"Sex. Health"},{"key":"ref_7","first-page":"9","article-title":"Vaccines against Emerging Sexually Transmitted Infections: Current Preventive Tools and Future Perspectives","volume":"45","author":"Raccagni","year":"2022","journal-title":"New Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: Challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","unstructured":"(2023, October 20). Sustainable Development Goals. United Nations. Available online: https:\/\/sdgs.un.org\/goals."},{"key":"ref_10","unstructured":"(2017). Global Priority List of Antibiotic-Resistant Bacteria, World Health Organization. Available online: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"key":"ref_11","unstructured":"(2016). WHO Guidelines for the Treatment of Neisseria Gonorrhoeae, World Health Organization. Available online: https:\/\/www.who.int\/publications-detail-redirect\/9789241549691."},{"key":"ref_12","unstructured":"(2023, October 20). Sexually Transmitted Disease Surveillance 2018, Available online: https:\/\/www.cdc.gov\/std\/stats18\/STDSurveillance2018-full-report.pdf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1001\/jama.2012.3428","article-title":"Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: A systematic review","volume":"307","author":"Chico","year":"2012","journal-title":"JAMA"},{"key":"ref_14","unstructured":"(2023, October 20). Gonorrhoea Annual Epidemiological Report for 2018. Stockholm, European Centre for Diseases Prevention and Control. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/gonorrhoea-annual-epidemiological-report-2018.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(13)61947-9","article-title":"Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: Findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)","volume":"382","author":"Sonnenberg","year":"2013","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Unigwe, I., Yang, S., Song, H.J., Lo-Ciganic, W.-H., Hincapie-Castillo, J., Cook, R.L., and Park, H. (2022). Trends in Sexually Transmitted Infections in United States Ambulatory Care Clinics from 2005\u20132016. J. Clin. Med., 11.","DOI":"10.3390\/jcm11010071"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Orzechowska, M., Cybulski, M., Krajewska-Kulak, E., Sobolewski, M., Gniadek, A., and Niczyporuk, W. (2022). Comparative Analysis of the Incidence of Selected Sexually Transmitted Viral Infections in Poland in 2010\u20132015: A Retrospective Cohort Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11123448"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1071\/SH19023","article-title":"World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): Review of new data and evidence to inform international collaborative actions and research efforts","volume":"16","author":"Unemo","year":"2019","journal-title":"Sex. Health"},{"key":"ref_19","unstructured":"(2019). Global Antimicrobial Resistance and Use Surveillance System (GLASS), World Health Organization. Available online: https:\/\/www.who.int\/initiatives\/glass."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/OLQ.0000000000001258","article-title":"Sexually Transmitted Infections in Pregnancy: A Narrative Review of the Global Research Gaps, Challenges, and Opportunities","volume":"47","author":"Grant","year":"2020","journal-title":"Sex. Transm. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/OLQ.0000000000000592","article-title":"Adverse Birth Outcomes and Maternal Neisseria gonorrhoeae Infection: A Population-Based Cohort Study in Washington State","volume":"44","author":"Heumann","year":"2017","journal-title":"Sex. Transm. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kondracki, A.J., Li, W., Bursac, Z., Mokhtari, M., Reddick, B., and Barkin, J.L. (2022). Interaction Effects of Maternal Sexually Transmitted Infections with Prenatal Care Utilization Status on Preterm Birth and Low Birthweight: U.S. National Data. J. Clin. Med., 11.","DOI":"10.3390\/jcm11175184"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/cid\/ciy958","article-title":"Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series","volume":"69","author":"Crew","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","first-page":"471","article-title":"Epidemiology and control of gonococcal ophthalmia neonatorum","volume":"67","author":"Laga","year":"1989","journal-title":"Bull. World Health Organ."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Guvenc, F., Kaul, R., and Gray-Owen, S.D. (2020). Intimate Relations: Molecular and Immunologic Interactions between Neisseria gonorrhoeaeand HIV-1. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01299"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/QAI.0b013e3181c3ef29","article-title":"Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion","volume":"53","author":"Bernstein","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"U.S. Preventive Services Task Force (2005). Screening for gonorrhea: Recommendation statement. Ann. Fam. Med., 3, 263\u2013267.","DOI":"10.1370\/afm.337"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e25343","DOI":"10.1002\/jia2.25343","article-title":"Diagnosing sexually transmitted infections in resource-constrained settings: Challenges and ways forward","volume":"22","author":"Wi","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14737159.2017.1360137","article-title":"Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae","volume":"17","author":"Low","year":"2017","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yang, J., Dhital, S., and Naderer, T. (2019). Efficacy and Safety of Injectable and Oral Antibiotics in Treating Gonorrhea: A Systematic Review and Network Meta-Analysis. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122182"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(21)00625-3","article-title":"Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): A randomised, non-inferiority trial","volume":"22","author":"Jongen","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_33","first-page":"S1198-743X(23)00564-5","article-title":"Single-dose cefixime 800 mg plus doxycycline 100 mg b.i.d. for 7 days compared to single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal and pharyngeal gonorrhoea: A randomised clinical trial","volume":"17","author":"Kubele","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/cid\/ciu521","article-title":"The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea","volume":"59","author":"Kirkcaldy","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s Treatment Guidelines for Gonococcal Infection, 2020","volume":"69","author":"Barbee","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2958.2005.04964.x","article-title":"Natural transformation of Neisseria gonorrhoeae: From DNA donation to homologous recombination","volume":"59","author":"Hamilton","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1800323","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","article-title":"Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018","volume":"23","author":"Eyre","year":"2018","journal-title":"Euro Surveill."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-158-5-201303050-00004","article-title":"Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: The Gonococcal Isolate Surveillance Project, 2005\u20132010","volume":"158","author":"Kirkcaldy","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Cocchetti, C., Romani, A., Mazzoli, F., Ristori, J., Lagi, F., Meriggiola, M.C., Motta, G., Pierdominici, M., Bartoloni, A., and Vignozzi, L. (2022). Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102774"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1071\/SH19034","article-title":"New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance","volume":"16","author":"Lewis","year":"2019","journal-title":"Sex. Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0897190017708073","article-title":"Solithromycin (CEM-101): A New Fluoroketolide Antibiotic and Its Role in the Treatment of Gonorrhea","volume":"31","author":"Mancuso","year":"2018","journal-title":"J. Pharm. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(19)30116-1","article-title":"Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): A randomised phase 3 non-inferiority trial","volume":"19","author":"Chen","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/OLQ.0000000000000971","article-title":"Efficacy and Safety of Single-Dose Oral Delafloxacin Compared with Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study","volume":"46","author":"Hook","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea","volume":"379","author":"Taylor","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acsinfecdis.0c00021","article-title":"Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates","volume":"6","author":"Bradford","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/cts.13487","article-title":"Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open-label randomized cross-over study in healthy subjects","volume":"16","author":"Luckey","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e0129221","DOI":"10.1128\/AAC.01292-21","article-title":"Thorough QT Study to Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults","volume":"65","author":"Newman","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","first-page":"e01808-18","article-title":"Single-Dose Pharmacokinetics, Excretion, and Metabolism of Zoliflodacin, a Novel Spiropyrimidinetrione Antibiotic, in Healthy Volunteers","volume":"63","author":"Lawrence","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/jac\/dkad060","article-title":"Gepotidacin: A novel, oral, \u2018first-in-class\u2019 triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea","volume":"78","author":"Watkins","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/sextrans-2022-055518","article-title":"Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea","volume":"99","author":"Hossain","year":"2023","journal-title":"Sex. Transm. Infect."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cid\/ciy145","article-title":"Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation","volume":"67","author":"Taylor","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_54","unstructured":"(2023, October 20). A Study Evaluating Efficacy and Safety of Gepotidacin Compared with Ceftriaxone plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhoea, Available online: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04010539."},{"key":"ref_55","unstructured":"(2023, October 20). Zoliflodacin in Uncomplicated Gonorrhoea, Available online: https:\/\/www.clinicaltrials.gov\/study\/NCT03959527."},{"key":"ref_56","unstructured":"(2023, November 24). Penetration of the Innovative Antibiotic Gepotidacin into Prostate and Tonsillar Tissue (AB-Direct), Available online: https:\/\/clinicaltrials.gov\/study\/NCT04484740."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/24\/7767\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:07Z","timestamp":1760132467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/24\/7767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":56,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["jcm12247767"],"URL":"https:\/\/doi.org\/10.3390\/jcm12247767","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]}}}